Trials / Unknown
UnknownNCT04154449
Effect of Intranasal Insulin on Postoperative Cognitive Dysfunction
Effect of Intranasal Insulin on Postoperative Cognitive Dysfunction in Middle Aged Patients Undergoing Non Cadiac Surgery.
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 57 (estimated)
- Sponsor
- Minia University · Academic / Other
- Sex
- All
- Age
- 40 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
Our study is designed to evaluate the effect of intranasal insulin on postoperative cognitive dysfunction. Primary outcome: 1\. The occurrence of cognitive dysfunction at approximately 7 days after surgery. Secondary outcome: 1\. Incidence of any side effect.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Intranasal insulin | Surgical group Received intranasal insulin, the second group surgical Received placebo and the third group is non surgical do not receive anything. |
Timeline
- Start date
- 2019-02-25
- Primary completion
- 2019-12-25
- Completion
- 2019-12-25
- First posted
- 2019-11-06
- Last updated
- 2019-11-06
Locations
2 sites across 1 country: Egypt
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04154449. Inclusion in this directory is not an endorsement.